Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JINARC DIN 02437538

Status: Marketed
Holder: OTSUKA PHARMACEUTICAL CO LTD
Molecule: TOLVAPTAN

Health Canada record

Active ingredient(s)TOLVAPTAN 90 MG; TOLVAPTAN 30 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC03XA01 TOLVAPTAN
Original market date01-Jun-2015
Current status date01-Jun-2015
SourceHealth Canada DPD

Establishment licence of the holder

Otsuka Pharmaceutical Co., Ltd. — licence , not currently licensed, last inspection rating C (2025-07-07).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TOLVAPTAN

DINProductCompanyFormStrengthStatus
02437511JINARCOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 60 MG; TOLVAPTAN 30 MGMarketed
02491583JINARCOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 30 MG; TOLVAPTAN 15 MGMarketed
02491575JINARCOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 15 MG; TOLVAPTAN 15 MGMarketed
02437503JINARCOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 45 MG; TOLVAPTAN 15 MGMarketed
02557215LUPIN-TOLVAPTANLUPIN PHARMA CANADA LIMITEDTabletTOLVAPTAN 90 MG; TOLVAPTAN 30 MGMarketed
02557185LUPIN-TOLVAPTANLUPIN PHARMA CANADA LIMITEDTabletTOLVAPTAN 30 MG; TOLVAPTAN 15 MGMarketed
02557193LUPIN-TOLVAPTANLUPIN PHARMA CANADA LIMITEDTabletTOLVAPTAN 45 MG; TOLVAPTAN 15 MGMarketed
02557207LUPIN-TOLVAPTANLUPIN PHARMA CANADA LIMITEDTabletTOLVAPTAN 60 MG; TOLVAPTAN 30 MGMarketed
02557177LUPIN-TOLVAPTANLUPIN PHARMA CANADA LIMITEDTabletTOLVAPTAN 15 MG; TOLVAPTAN 15 MGMarketed
02370484SAMSCAOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 60 MGApproved
02370476SAMSCAOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 30 MGMarketed
02370468SAMSCAOTSUKA PHARMACEUTICAL CO LTDTabletTOLVAPTAN 15 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
166402015-02-25New Drug Submission (NDS)

International API supply for TOLVAPTAN

19 active FDA Drug Master Files.

Request a quote for JINARC

How to read a Canadian DIN record